The ESO Masterclass: where those most eager to learn meet those most willing to teach
The annual week-long course lies at the very heart of ESO’s mission and shapes the oncology leaders of tomorrow. Download full article
2011
A minimum acceptable standard of care for every patient
How can we transmit knowledge about cancer patients’ needs to the people who have the power to act, in a way they can quickly and easily understand? Download full article
Denosumab – a new option for solid tumours metastatic to bone
Zoledronic acid is a potent bisphosphonate used as the standard therapy for the prevention of skeletal-related events in patients with solid tumours metastatic to bone. Three phase III studies have reported head-to-head comparisons of zoledronic [more]
Perioperative therapy improves gastro-oesophageal cancer survival
A randomised phase III study has reported significant improvements in RO resection rate and overall survival associated with perioperative cisplatin and 5-fluorouracil treatment compared with surgery alone in patients with gastro-oesophageal adenocarcinoma. These data support [more]
Newsround
Cancer family histories found to be inaccurate Download full article
For the love of the job
Elisabeth de Vries enjoys investigating whether we can push the potential of imaging techniques to the point where a patient’s response to a drug can routinely be measured in an outpatient clinic. Download full article
Unshackling progress in the care of childhood cancers
A meeting held in the run up to International Childhood Cancer Day reviewed how well we are doing to help young cancer patients. Download full article
Think yourself better
In oncology, the contribution of the human touch which alternative medical treatments offer, and the placebo effect they induce, can be easy to overlook. Download full article
Rituximab for follicular lymphoma: maintaining an open mind
New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations of cost, inconvenience, toxic effects, efficacy of retreatment [more]
ASTER–another flow in the diagnostic field of lung cancer?
Mediastinal staging of patients with lung cancer is used to avoid futile thoracotomies. Endoscopic, oesophageal and bronchial ultrasound procedures are methods to identify involved lymph nodes. The ASTER study indicates that the sensitivity of these [more]
Newsround
Selected reports by Janet Fricker Download full article
Patients need information. Is that clear?
The urgent quest for novel cancer treatments engages much of our attention, but could we be overlooking other opportunities for increasing patients’ survival and quality of life? Download full article
Peter Naredi: a can do’ leader for Europe’s cancer surgeons
There are so many ways cancer surgeons can help improve outcomes, and Peter Naredi embraces them all. As ESSO president, he now hopes to enthuse Europe’s cancer surgeons to follow his lead. Download full article